BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 23341234)

  • 1. Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease.
    Inns J; James V
    Breast; 2015 Aug; 24(4):364-9. PubMed ID: 25957467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM: a novel breast cancer dissemination marker for the assessment of metastatic risk.
    Oktay MH; Jones JG
    Biomark Med; 2015; 9(2):81-4. PubMed ID: 25689896
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular markers for breast cancer: prediction on tumor behavior.
    Banin Hirata BK; Oda JM; Losi Guembarovski R; Ariza CB; de Oliveira CE; Watanabe MA
    Dis Markers; 2014; 2014():513158. PubMed ID: 24591761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of traditional serum biomarkers for management of breast cancer patients.
    Mirabelli P; Incoronato M
    Biomed Res Int; 2013; 2013():685641. PubMed ID: 24350285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperresistinemia and metabolic dysregulation: a risky crosstalk in obese breast cancer.
    Crisóstomo J; Matafome P; Santos-Silva D; Gomes AL; Gomes M; Patrício M; Letra L; Sarmento-Ribeiro AB; Santos L; Seiça R
    Endocrine; 2016 Aug; 53(2):433-42. PubMed ID: 26892376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly Imprinted Polymers for the Determination of Cancer Biomarkers.
    Pilvenyte G; Ratautaite V; Boguzaite R; Ramanavicius A; Viter R; Ramanavicius S
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving breast cancer prediction using a pattern recognition network with optimal feature subsets.
    Gündoğdu S
    Croat Med J; 2021 Oct; 62(5):480-487. PubMed ID: 34730888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iterative principal component analysis method for improvised classification of breast cancer disease using blood sample analysis.
    R G; G S
    Med Biol Eng Comput; 2021 Oct; 59(10):1973-1989. PubMed ID: 34331636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them.
    Smith MT; Guyton KZ; Kleinstreuer N; Borrel A; Cardenas A; Chiu WA; Felsher DW; Gibbons CF; Goodson WH; Houck KA; Kane AB; La Merrill MA; Lebrec H; Lowe L; McHale CM; Minocherhomji S; Rieswijk L; Sandy MS; Sone H; Wang A; Zhang L; Zeise L; Fielden M
    Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):1887-1903. PubMed ID: 32152214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism.
    Yoneten KK; Kasap M; Akpinar G; Gunes A; Gurel B; Utkan NZ
    Cancer Genomics Proteomics; 2019; 16(5):377-397. PubMed ID: 31467232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematical Identification of Breast Cancer-Related Circular RNA Modules for Deciphering circRNA Functions Based on the Non-Negative Matrix Factorization Algorithm.
    Wang S; Xia P; Zhang L; Yu L; Liu H; Meng Q; Liu S; Li J; Song Q; Wu J; Wang W; Yang L; Xiao Y; Xu C
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Resistin, glucose, age and BMI to predict the presence of breast cancer.
    Patrício M; Pereira J; Crisóstomo J; Matafome P; Gomes M; Seiça R; Caramelo F
    BMC Cancer; 2018 Jan; 18(1):29. PubMed ID: 29301500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized vertical GaN micro pillar arrays with high signal-to-background ratio for detection and analysis of proteins secreted from breast tumor cells.
    Choi MK; Kim GS; Jeong JT; Lim JT; Lee WY; Umar A; Lee SK
    Sci Rep; 2017 Nov; 7(1):14917. PubMed ID: 29097674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-linked gene 2 promotes breast cancer growth and metastasis by regulating the cytoskeleton.
    Qin J; Li D; Zhou Y; Xie S; Du X; Hao Z; Liu R; Liu X; Liu M; Zhou J
    Oncotarget; 2017 Jan; 8(2):2745-2757. PubMed ID: 27926525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements.
    He HJ; Almeida JL; Lund SP; Steffen CR; Choquette S; Cole KD
    Biomol Detect Quantif; 2016 Jun; 8():1-8. PubMed ID: 27335805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression correlation for cancer diagnosis: a pilot study.
    Ling B; Chen L; Liu Q; Yang J
    Biomed Res Int; 2014; 2014():253804. PubMed ID: 24818135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer biomarker measurements and standards.
    Cole KD; He HJ; Wang L
    Proteomics Clin Appl; 2013 Jan; 7(1-2):17-29. PubMed ID: 23341234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.